Yi-Hsuan Lin MD , Chia-Hung Lin MD, PhD , Yu-Chih Lin MD , Yu-Yao Huang MD, PhD , An-Shun Tai PhD , Shih-Chen Fu PhD , Sheng-Hsuan Lin MD, ScD, ScM
{"title":"葡萄糖钠转运体 2 抑制剂与基于胰岛素的疗法相比可降低糖尿病足病患者因心力衰竭住院的风险和截肢率:一项基于全国人口的研究》[《内分泌实践》30 (5) (2024) 第 424-430 页]。","authors":"Yi-Hsuan Lin MD , Chia-Hung Lin MD, PhD , Yu-Chih Lin MD , Yu-Yao Huang MD, PhD , An-Shun Tai PhD , Shih-Chen Fu PhD , Sheng-Hsuan Lin MD, ScD, ScM","doi":"10.1016/j.eprac.2024.06.012","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":"30 9","pages":"Page 898"},"PeriodicalIF":4.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1530891X24005937/pdfft?md5=e6f879a1e00b610165e0aa2b5eb4f678&pid=1-s2.0-S1530891X24005937-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430]\",\"authors\":\"Yi-Hsuan Lin MD , Chia-Hung Lin MD, PhD , Yu-Chih Lin MD , Yu-Yao Huang MD, PhD , An-Shun Tai PhD , Shih-Chen Fu PhD , Sheng-Hsuan Lin MD, ScD, ScM\",\"doi\":\"10.1016/j.eprac.2024.06.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11682,\"journal\":{\"name\":\"Endocrine Practice\",\"volume\":\"30 9\",\"pages\":\"Page 898\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1530891X24005937/pdfft?md5=e6f879a1e00b610165e0aa2b5eb4f678&pid=1-s2.0-S1530891X24005937-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1530891X24005937\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1530891X24005937","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430]
期刊介绍:
Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.